TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Scius Pharma Support AB
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
542
|
662
|
1,022 |
Financial expenses |
0
![]() |
0
![]() |
0 |
Earnings before taxes |
-195
|
41
|
334 |
EBITDA |
-197
|
41
|
334 |
Total assets |
701
|
1,060
|
1,377 |
Current assets |
701
|
1,060
|
1,377 |
Current liabilities |
80
|
61
|
119 |
Equity capital |
621
|
1,000
|
1,258 |
- share capital |
34
|
33
|
36 |
Employees (average) |
1
![]() |
1
![]() |
1 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
88.6%
|
94.3%
|
91.4% |
Turnover per employee |
542
|
662
|
1,022 |
Profit as a percentage of turnover |
-36.0%
|
6.2%
|
32.7% |
Return on assets (ROA) |
-27.8%
|
3.9%
|
24.3% |
Current ratio |
876.2%
|
1737.7%
|
1157.1% |
Return on equity (ROE) |
-31.4%
|
4.1%
|
26.6% |
Change turnover |
-123
|
-278
|
440 |
Change turnover % |
-18%
|
-30%
|
76% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.